Transaction · 0001214659-26-011121

Ault Milton C III

AULT MILTON C III, DIR, reported an open-market or private sale at Alzamend Neuro, Inc. involving 2000.000000 shares for an estimated $3116.20. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
ALZNAlzamend Neuro, Inc.
Estimated value-$3.11kShares × reported price
Shares traded2.00k$1.56 per share
Holdings after0Direct
% of reported position traded100%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 2,000 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ALZN price since this filing

Daily closing prices, with the filing date and available return windows
ALZN · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -16.3%1w ago -5.0%1d ago +0.6%
Returns since7d +3.8%30d +13.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001214659-26-011121
Common Stock
Transaction date
Aug 26, 2026
Filed Aug 31, 2026, 10:05 AM · 5d delay
Shares
2,000 sh
$1.56 per share
Estimated value
-$3.11k
Computed from shares × price
Holdings after
0 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sale of these shares is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such ma…

  2. F2

    The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $1.5581. The range of sale prices on the transaction…

  3. F3

    Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Capital Group, Inc. ("ACG"). ACG is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairma…

  4. F4

    Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.

  5. F5

    Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.

Original filing · 0001214659-26-011121
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ALZN